No matching items found
SHOWING Results
Gulf Pharmaceutical Industries (Julphar), one of the largest pharmaceutical manufacturers in the Middle East and Africa, reported its financial results for the second quarter. The Company reported robust results achieving...
Gulf Pharmaceutical Industries (Julphar) reported on Tuesday its financial results for the first quarter ending March 31, 2022, announcing Dhs418.6 million in net sales in first quarter of 2022, a...
The value of Dubai’s external pharmaceutical and medical supplies trade reached Dhs6.8 billion for Q1, 2021 recording a growth of 31 per cent from Dhs5.2 billion in the same period...
The fresh wave of Covid-19 in the country has pushed up sales of medicines and resulted in exponential growth for the pharmaceutical sector. According to total sales audit data from...
The exports of Pakistan’s pharmaceutical products during the first three months of current fiscal year grew by 22.60 per cent as compared to the exports of the corresponding period of...
Ben Chu, The Independent Imagine how potentially profitable a coronavirus vaccine could be. Seven and a half billion people across the world, with perhaps a majority in need of vaccination....
Business Bureau, Gulf Today Dubai Economy issued fines to nine pharmacies and two pharmaceuticals suppliers for inflating the prices of face masks and trying to take undue advantage of the...
Inayat-ur-Rahman Neopharma, a leading global pharmaceutical company based in the UAE and GlaxoSmithKline (GSK) the global science-led healthcare company, have announced the launch of the first ever locally produced...
Greg Frank, Tribune News Service We’re crawling on your skin. Teeming under your toenails. And lurking on your doorknobs and countertops. We’re drug-resistant microbes, immune to all but your strongest...
Novartis is buying dry-eye medicine brand ‘Xiidra’ from Takeda Pharmaceutical for up to $5.3 billion as the Swiss pharma-maker refreshes its ophthalmic medicines portfolio with a potential blockbuster. The deal...
